These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19594543)

  • 1. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
    Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
    Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
    J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of VEGF gene polymorphisms in the clinical outcome of non-small cell lung cancer.
    Chen N; Ma CN; Zhao M; Zhang YJ
    Genet Mol Res; 2015 Dec; 14(4):16006-11. PubMed ID: 26662393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
    Guan X; Yin M; Wei Q; Zhao H; Liu Z; Wang LE; Yuan X; O'Reilly MS; Komaki R; Liao Z
    BMC Cancer; 2010 Aug; 10():431. PubMed ID: 20712888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.
    Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
    Oncol Rep; 2013 Jan; 29(1):39-44. PubMed ID: 23064377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
    Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
    J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
    Bradbury PA; Zhai R; Ma C; Xu W; Hopkins J; Kulke MJ; Asomaning K; Wang Z; Su L; Heist RS; Lynch TJ; Wain JC; Christiani D; Liu G
    Clin Cancer Res; 2009 Jul; 15(14):4680-5. PubMed ID: 19584152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Yuan X; Guan X; O'Reilly MS; Welsh J; Wang LE; Wei Q
    Cancer Sci; 2012 May; 103(5):945-50. PubMed ID: 22320189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
    Liu L; Zhou F; Ren S; Chen X; Li X; Li W; Zhou C
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e339-46. PubMed ID: 25131817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.
    Yoshida H; Nomizo T; Ozasa H; Tsuji T; Funazo T; Yasuda Y; Ajimizu H; Yamazoe M; Kuninaga K; Ogimoto T; Hosoya K; Itotani R; Sakamori Y; Kim YH; Hirai T
    Eur J Cancer; 2021 Feb; 144():317-325. PubMed ID: 33385948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
    Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
    Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.
    Masago K; Togashi Y; Fujita S; Nagai H; Sakamori Y; Okuda C; Kim YH; Mishima M
    Oncology; 2013; 84(4):214-8. PubMed ID: 23364242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
    Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
    Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
    Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
    Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
    Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
    Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
    Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
    Zhong W; Wang X; Pan B; Su Z
    Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Qi H; Zhang W; Wang Y; Ge M; Wang T; Zhang L; Zhong M; Shi X; Liang X; Zhan Q; Li Q
    J Chemother; 2023 Feb; 35(1):53-62. PubMed ID: 35262460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.